These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18083536)

  • 1. Hemoglobin and overt nephropathy complications in type 1 diabetes.
    Conway B; Fried L; Orchard T
    Ann Epidemiol; 2008 Feb; 18(2):147-55. PubMed ID: 18083536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
    Harjutsalo V; Thomas MC; Forsblom C; Groop PH;
    Diabetes Obes Metab; 2018 Dec; 20(12):2759-2767. PubMed ID: 29962015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset.
    Costacou T; Orchard TJ
    Diabetes Care; 2018 Mar; 41(3):426-433. PubMed ID: 28931542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
    Kleine CE; Soohoo M; Ranasinghe ON; Park C; Marroquin MV; Obi Y; Rhee CM; Moradi H; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2018; 47(5):333-342. PubMed ID: 29779027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
    Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
    Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.
    Williams KV; Cristaldi CL; Miller RG; Arena VC; Libman I; Huang Y; Becker DJ; Orchard TJ
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3828-3836. PubMed ID: 30099548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
    Mohammedi K; Potier L; Belhatem N; Matallah N; Hadjadj S; Roussel R; Marre M; Velho G
    Cardiovasc Diabetol; 2016 Jan; 15():5. PubMed ID: 26743116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
    Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
    Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.
    Mohanram A; Zhang Z; Shahinfar S; Keane WF; Brenner BM; Toto RD
    Kidney Int; 2004 Sep; 66(3):1131-8. PubMed ID: 15327408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anemia with outcomes in men with moderate and severe chronic kidney disease.
    Kovesdy CP; Trivedi BK; Kalantar-Zadeh K; Anderson JE
    Kidney Int; 2006 Feb; 69(3):560-4. PubMed ID: 16395253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes.
    Hadjadj S; Cariou B; Fumeron F; Gand E; Charpentier G; Roussel R; Kasmi AA; Gautier JF; Mohammedi K; Gourdy P; Saulnier PJ; Feigerlova E; Marre M;
    Diabetologia; 2016 Jan; 59(1):208-216. PubMed ID: 26486355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.
    Bentata Y; Haddiya I; Latrech H; Serraj K; Abouqal R
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):392-402. PubMed ID: 23538374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
    Alkhalaf A; Bakker SJ; Bilo HJ; Gans RO; Navis GJ; Postmus D; Forsblom C; Groop PH; Vionnet N; Hadjadj S; Marre M; Parving HH; Rossing P; Tarnow L
    Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
    J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.
    Costacou T; Fried L; Ellis D; Orchard TJ
    Am J Kidney Dis; 2011 Oct; 58(4):565-73. PubMed ID: 21840097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.